Manufacturers must navigate complex regulatory landscapes, understand diverse cultural nuances, and prioritize patient access in each region.
Thomas Ruggia
Advertisement
President and CEO, Samsara Vision
Articles by Thomas Ruggia
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Bristol Myers Squibb Enters $1.5 Billion Definitive Agreement Acquiring Orbital Therapeutics
2
Most Favored Nation Order: Legal Battles, Market Shifts, and the Future of Drug Pricing Reform
3
AstraZeneca to Announce Deal with Trump Administration: Report
4
FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma
5
